Amerikanische Gesellschaft für Hirudotherapie

Controversy: hirudotherapy (leech therapy) as an alternative treatment for osteoarthritis

Gunawan F, Wibowo YR, Bunawan NC, Turner JH (2015) · Acta Medica Indonesiana · n=0

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidenceCondition: Knee Osteoarthritis

Study Profile

Design
narrative review article on the role of hirudotherapy in osteoarthritis management (Faculty of Medicine, Universitas Atma Jaya, Jakarta, Indonesia)
Sample size (n)
0
Intervention
Discussion of hirudotherapy as an alternative or complementary treatment for OA in the context of AAOS-recommended pharmacologic options (acetaminophen, NSAIDs, tramadol, capsaicin, corticosteroids)
Comparator
Conceptual comparison to AAOS-recommended pharmacologic options with attention to long-term side-effect profile
Primary endpoint
Qualitative assessment of hirudotherapy efficacy and safety in osteoarthritis
Primary result
Hirudotherapy described as a therapeutic modality with purported analgesic and anti-inflammatory properties, presented as one of several investigational alternatives motivated by long-term safety concerns with NSAIDs and other pharmacologic OA treatments
Follow-up duration
not applicable (review)

Key Findings

  • Indonesian academic review introducing hirudotherapy as an alternative to AAOS-recommended pharmacologic OA treatments
  • Frames hirudotherapy within the context of concerns about long-term NSAID, acetaminophen, and corticosteroid side-effects
  • Synthesizes purported analgesic and anti-inflammatory mechanisms of leech saliva
  • Useful international reference for the position of hirudotherapy in OA management outside the European tradition
  • Notes ongoing need for higher-quality investigative work to establish leech therapy in OA practice

Limitations

  • Narrative review only - no systematic search, quality grading, or quantitative synthesis
  • Short paper in a regional journal - limited depth on individual trials
  • Includes general mechanistic discussion that is not primary evidence
  • No GRADE rating
  • Cites earlier trials without independent quality assessment

Clinical Implications

Gunawan 2015 provides an Indonesian academic-medicine framing of hirudotherapy as one of several alternative OA treatments to be considered given long-term NSAID concerns. The review's principal value is as international context: it shows that the European leech-OA literature has received critical engagement in Southeast Asian academic medicine. For ASH editorial purposes, this review is cited only as contextual evidence of cross-cultural interest in hirudotherapy as an OA option, not as primary evidence. Effect-size estimates and recommendations should continue to draw on underlying RCTs and meta-analyses (Lauche 2014, Wang 2018).

Related Trials

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.